+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Olaparib + bevacizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
Lenvatinib + pembrolizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lenvatinib + pembrolizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Opdualag (Nivolumab and Relatlimab) Drug Insight and Market Forecast - 2035 - Product Thumbnail Image

Opdualag (Nivolumab and Relatlimab) Drug Insight and Market Forecast - 2035

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
Elotuzumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Elotuzumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
TIGIT Inhibitors - Competitive Landscape, 2022 - Product Thumbnail Image

TIGIT Inhibitors - Competitive Landscape, 2022

  • Report
  • October 2022
  • 100 Pages
  • Global
From
Oncolytic Virus - Competitive Landscape, 2022 - Product Thumbnail Image

Oncolytic Virus - Competitive Landscape, 2022

  • Report
  • October 2022
  • 300 Pages
  • Global
From
FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • September 2022
  • 30 Pages
  • Global
From
From
From
Cutaneous T-Cell Lymphoma(CTCL) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma(CTCL) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 150 Pages
  • Global
From
From
Benralizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Benralizumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Head and Neck Cancer (HNC) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 116 Pages
  • Global
From
From
Gazyva Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Gazyva Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Masitinib Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Masitinib Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more